The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
about
Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionAA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of TumorsDNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognitionMathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival RatesTopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.Targeting cancer stem cells with p53 modulators.Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.Cancer stem cells and early stage basal-like breast cancer.Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination.p53 and its mutants on the slippery road from stemness to carcinogenesis.Pharmacogenomics of Scopoletin in Tumor Cells.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers.p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity.Mathematical modeling and computational prediction of cancer drug resistance.p53 shades of Hippo.Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model.Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells.Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.Rlip depletion prevents spontaneous neoplasia in TP53 null mice.Carcinogenesis: integrative Cancer Research has concluded its 35th year in the service of the scientific community.p53 and metabolism: from mechanism to therapeutics.Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
P2860
Q27311035-DA1689C3-FACE-40A7-9BC7-177BC0D19E35Q33838881-5775838E-614A-4CCF-91B9-00A160D2DE42Q34499162-20AA5410-859A-43B8-89E8-2D57E17028ECQ35830047-8CA14F62-ABEB-4CA6-B429-15772FD2CBB4Q35930811-8CFAC124-EB87-4FC2-87A4-CED2FF4BDEF9Q36289944-9DCE490F-1CB4-41A5-8A07-47CDC0D53EAFQ36544290-3D9CD601-9FAE-4DBA-955E-F9F521523445Q36634818-8A880312-B7AA-4717-88ED-0D5B55A0D217Q37296242-697D83F3-F421-4CE4-9B84-23CF5B62D4E7Q37478627-0E9BE712-A50F-447B-8A55-092426463EACQ37564349-C1F032D0-FEAD-4C30-8878-DAF60C5656CDQ37640084-8B357279-BEC3-42F0-BCFA-E7557662592CQ37660438-68D8B410-2FA5-4034-AB2D-C0B4350335E9Q37665545-57FD0ACF-B24A-407A-9120-501E03B1DEFAQ38740922-2AA264DC-327D-4A9F-A50F-E50363D62E1EQ38777193-EA1E726B-7DAD-4ECA-98EC-27F72C10F4C1Q38846785-0FF9C685-44D7-485C-9C4B-53481F4ABBF3Q41549887-66D09A0E-01E8-470A-8B66-7E8DE671AAA1Q43293646-110E10F3-655A-4D58-9D79-42625D1C14B3Q47660509-032104D0-A66A-4C98-B6BC-6E865158643AQ47850800-E58EF1AB-9593-4394-8FB9-6058E69830DFQ48507301-29467199-943D-475B-824E-209511F9596AQ49486366-E72075C4-F627-4301-84ED-17114CC1AA7AQ49988786-C77A76AD-D7DA-4F64-9F47-7B56F51B257AQ52724571-8A66AC66-AE5A-4351-B867-8985927E6998Q53225042-FFFDEEFB-2582-460C-8F67-6739A4FA16BEQ55002919-B1B3B21C-8E9B-4710-8014-729D295F63EAQ58796644-1D09277A-CAFB-4F43-96CE-87715B8008B3
P2860
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
@en
type
label
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
@en
prefLabel
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
@en
P2093
P2860
P356
P1433
P1476
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
@en
P2093
Alina Molchadsky
Hilla Solomon
Stav Horesh
Varda Rotter
Yoav Shetzer
P2860
P304
P356
10.1093/CARCIN/BGU073
P407
P577
2014-03-21T00:00:00Z